Clinical Trial Update: Cetuximab + Gemox in Biliary Tract Cancer [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluating cetuximab with gemcitabine and oxaliplatin (GemOx) for unresectable or locally advanced biliary tract cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Eloxatin (oxaliplatin)
• Gemzar (gemcitabine)

Snippet

Sponsor: Association of Research on the Biology of Liver Tumors | Conditions: Unresectable, Locally Advanced | Phase 2 | Status: COMPLETED